Benzinga | May 17, 2021 07:20AM EDT

Altimmune Q1 EPS $(0.38) Beats $(0.47) Estimate, Sales $837.52K Down From $2.21M YoY

Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.47) by 19.15 percent. This is a 46.15 percent decrease over losses of $(0.26) per share from the same period last year. The company reported $837.52 thousand in sales this quarter. This is a 62.15 percent decrease over sales of $2.21 million the same period last year.